BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Driedger MR, Dixon E, Mohamed R, Sutherland FR, Bathe OF, Ball CG. The diagnostic pathway for solid pancreatic neoplasms: are we applying too many tests? J Surg Res. 2015;199:39-43. [PMID: 25953217 DOI: 10.1016/j.jss.2015.04.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Birnbaum DJ, Gaujoux S, Berbis J, Dokmak S, Hammel P, Vullierme MP, Lévy P, Sauvanet A. Surgery for pancreatic neoplasms: How accurate are our surgical indications? Surgery 2017;162:112-9. [DOI: 10.1016/j.surg.2017.01.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
2 Joo I, Lee JM, Lee DH, Lee ES, Paeng JC, Lee SJ, Jang J, Kim S, Ryu JK, Lee K. Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study. Radiology 2017;282:149-59. [DOI: 10.1148/radiol.2016152798] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
3 Joo I, Lee JM, Lee ES, Ahn SJ, Lee DH, Kim S, Ryu JK, Oh D, Kim K, Lee K, Jang J. Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy. American Journal of Roentgenology 2018;210:1059-65. [DOI: 10.2214/ajr.17.18310] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lukács G, Kovács Á, Csanádi M, Moizs M, Repa I, Kaló Z, Vokó Z, Pitter JG. Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence. Cancer Manag Res 2019;11:9849-61. [PMID: 31819622 DOI: 10.2147/CMAR.S221427] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Deshwar AB, Sugar E, Torto D, De Jesus-Acosta A, Weiss MJ, Wolfgang CL, Le D, He J, Burkhart R, Zheng L, Laheru D, Yarchoan M. Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis. Ann Pancreat Cancer 2018;1:13. [PMID: 29683142 DOI: 10.21037/apc.2018.02.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Arya N, Wyse JM, Jayaraman S, Ball CG, Lam E, Paquin SC, Lightfoot P, Sahai AV. A proposal for the ideal algorithm for the diagnosis, staging, and treatment of pancreas masses suspicious for pancreatic adenocarcinoma: Results of a working group of the Canadian Society for Endoscopic Ultrasound. Endosc Ultrasound 2020;9:154-61. [PMID: 32584310 DOI: 10.4103/eus.eus_28_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 The RICOCHET Study Group, West Midlands Research Collaborative. Receipt of Curative Resection or Palliative Care for Hepatopancreaticobiliary Tumours (RICOCHET): Protocol for a Nationwide Collaborative Observational Study. JMIR Res Protoc 2019;8:e13566. [DOI: 10.2196/13566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Feng Q, Li C, Zhang S, Tan CL, Mai G, Liu XB, Chen YH. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis. World J Gastroenterol 2019; 25(39): 6006-6015 [PMID: 31660036 DOI: 10.3748/wjg.v25.i39.6006] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]